David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
PUT
Hims & Hers Health
HIMS
$7.53B
| $8.68M | 0.01% |
359,100
+275,400
| +329% | +$6.82M |
|
|
ACH
1477
Accendra Health
ACH
$83.8M
| $8.67M | 0.01% |
663,718
-78,671
| -11% | -$1.05M |
|
1478
PUT
On Holding
ONON
$9.7B
| $8.66M | 0.01% |
158,100
+135,100
| +587% | +$7.16M |
|
|
SBXD
1479
SilverBox Corp IV
SBXD
$285M
| $8.65M | 0.01% |
+857,397
| New | +$8.61M |
|
|
EXK
1480
Endeavour Silver
EXK
$3.27B
| $8.64M | 0.01% |
2,360,444
+176,899
| +8% | +$782K |
|
1481
CALL
Halliburton
HAL
$28.4B
| $8.61M | 0.01% |
316,700
+266,700
| +533% | +$7.8M |
|
1482
Lear
LEA
$8.26B
| $8.61M | 0.01% |
90,873
+58,788
| +183% | +$5.86M |
|
1483
Community Health Systems
CYH
$420M
| $8.59M | 0.01% |
2,872,155
-726,777
| -20% | -$3.05M |
|
1484
CALL
S&P Global
SPGI
$128B
| $8.57M | 0.01% |
17,200
+15,200
| +760% | +$7.71M |
|
1485
Credit Acceptance
CACC
$6.29B
| $8.55M | 0.01% |
18,204
| – | – |
|
1486
CrowdStrike
CRWD
$191B
| $8.54M | 0.01% |
99,840
-1,056,080
| -91% | -$87.8M |
|
1487
Citizens Financial Group
CFG
$29.4B
| $8.54M | 0.01% |
195,146
-940,863
| -83% | -$41.6M |
|
1488
Keysight
KEYS
$54.1B
| $8.53M | 0.01% |
53,117
-323,791
| -86% | -$52.2M |
|
1489
Kodiak Sciences
KOD
$2.46B
| $8.48M | 0.01% |
852,076
-66,684
| -7% | -$383K |
|
1490
Viridian Therapeutics
VRDN
$2.76B
| $8.47M | 0.01% |
442,070
+304,003
| +220% | +$6.61M |
|
1491
Designer Brands
DBI
$285M
| $8.46M | 0.01% |
1,583,727
+89,846
| +6% | +$503K |
|
1492
PUT
Peloton Interactive
PTON
$2.37B
| $8.44M | 0.01% |
970,000
+170,000
| +21% | +$1.32M |
|
1493
PUT
Carpenter Technology
CRS
$24B
| $8.43M | 0.01% |
49,700
+15,000
| +43% | +$2.57M |
|
1494
Element Solutions
ESI
$8.59B
| $8.42M | 0.01% |
330,987
+311,649
| +1,612% | +$8.42M |
|
1495
PUT
Prologis
PLD
$136B
| $8.41M | 0.01% |
79,600
-8,300
| -9% | -$954K |
|
1496
CALL
Brinker International
EAT
$10.7B
| $8.41M | 0.01% |
63,600
+31,200
| +96% | +$3.51M |
|
1497
Freedom Holding
FRHC
$10.7B
| $8.41M | 0.01% |
64,369
+59,124
| +1,127% | +$6.79M |
|
1498
PUT
Lithia Motors
LAD
$8.16B
| $8.4M | 0.01% |
23,500
+6,200
| +36% | +$2.18M |
|
1499
Daktronics
DAKT
$918M
| $8.38M | 0.01% |
497,289
-38,652
| -7% | -$583K |
|
1500
CALL
Alcoa
AA
$13.4B
| $8.37M | 0.01% |
221,600
-80,300
| -27% | -$3.34M |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.